Co-occurring substance use, HIV and/or hepatitis C
Monday, November 2, 2015: 10:30 a.m. - 12:00 p.m.
This session focuses on the population with co-occurring substance use disorders (primarily injection drug use) and HIV and/or Hepatitis C virus infection. Presentations will cover the epidemiology and prevention and treatment options for this hard to reach, but extremely important patient population.
Session Objectives: Evaluate progress in placing HIV seropositive persons who inject drugs (PWID) onto antiretroviral treatment (ART) in New York City over the last 15 years
Identify major objectives for new harm reduction programs and methods to achieve them
Identify HCV incident infections in a sample of people who inject drug and reside in suburbs in southwestern Connecticut during a two year longitudinal study
Describe the prevalence of hepatitis C virus among different groups of people who use drugs in New York City
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: HIV/AIDS, Population, Reproductive and Sexual Health, Caucus on Homelessness
Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)
Masters Certified Health Education Specialist (MCHES)